Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)
| 1.80 Delayed Data As of Mar 27 |  -0.15 / -7.69%Today’s Change | 1.13 Today|||52-Week Range 7.27 | -56.63% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $193.1M |
Company Description
Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include XERMELO, Zynquista, and LX9211. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.
Contact Information
Lexicon Pharmaceuticals, Inc. 8800 Technology Forest Place The Woodlands Texas 77381-1160 |
Employees
Shareholders
| Other institutional | 82.96% |
| Individual stakeholders | 66.16% |
| Mutual fund holders | 18.10% |
Top Executives
| There are no executives to display. |
